Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

Company Profiles
Target Profiles
Product Profiles

Explore BCIQ profiles by entering a company name.

REQUEST A FREE TRIAL

Ra Capital Management L.P.

Name: Ra Capital Management L.P. - BioCentury Company Profiles - BCIQ
Creator: Biocentury

Headquarters: Boston, MA, United States of America

Website: https://www.racap.com/

Year Founded: 2004

Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Mar 5, 2025

Emerging Company Profile

Bambusa: Combining validated I&I targets in bispecifics to broaden efficacy

With $105M in venture funding, Bambusa has moved quickly towards the clinic with bispecifics in-licensed from antibody powerhouse Biotheus

BioCentury | Sep 19, 2024

Finance

Series A cash for Brenus, GCTx, Nura among week’s VC highlights

Also in BioCentury’s latest Venture Report: New investment initiatives from Novo and RA Capital

BioCentury | Aug 7, 2024

Emerging Company Profile

Diagonal: Gluing receptor complexes back together

Newco uses AI/ML to find bispecific antibodies that can reassemble functional receptor complexes in the face of mutations

BioCentury | Feb 3, 2024

Finance

Series A companies: the class of 2023

An analysis of the technologies behind last year’s biotech series A raisers finds clusters in mitophagy induction, epigenome editing and delivery vectors

BioCentury | Apr 26, 2023

Politics, Policy & Law